End Cash: The amount of cash held by the company for the given period.
Aurinia Pharmaceuticals Inc (AUPH) had End Cash of $179.83M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$83.22M |
|
$37.41M |
|
$6.55M |
|
$76.67M |
|
$43.11M |
|
$40.11M |
|
$8.68M |
|
$48.79M |
|
$48.79M |
|
$37.41M |
|
$37.41M |
|
$37.41M |
|
$37.41M |
|
$40.11M |
|
$44.94M |
|
130.08M |
|
133.53M |
|
$0.29 |
|
$0.28 |
|
| Balance Sheet Financials | |
$541.32M |
|
$1.86M |
|
$250.94M |
|
$792.26M |
|
$99.89M |
|
$43.94M |
|
$77.50M |
|
$177.40M |
|
$614.86M |
|
$611.49M |
|
$614.86M |
|
132.91M |
|
| Cash Flow Statement Financials | |
$85.13M |
|
$63.37M |
|
$-48.88M |
|
$80.21M |
|
|
End Cash |
$179.83M |
$99.62M |
|
$1.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.42 |
|
-- |
|
-- |
|
0.07 |
|
0.10 |
|
92.12% |
|
48.19% |
|
48.19% |
|
-- |
|
58.62% |
|
44.96% |
|
$85.09M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.15 |
|
2.02 |
|
44.49 |
|
6.08% |
|
6.12% |
|
4.72% |
|
5.68% |
|
$4.63 |
|
$0.64 |
|
$0.64 |
|